Framingham risk score and prediction of lifetime risk for coronary heart disease.
暂无分享,去创建一个
Ralph B D'Agostino | Daniel Levy | Martin G Larson | D. Levy | R. D'Agostino | P. Wilson | D. Lloyd‐Jones | M. Larson | A. Beiser | E. Leip | Donald M Lloyd-Jones | Peter W F Wilson | Eric P Leip | Alexa Beiser | P. Wilson | D. Levy
[1] Enrique Sanchez-Delgado,et al. Lifetime risk of developing coronary heart disease , 1999, The Lancet.
[2] D. Levy,et al. Lifetime risk of coronary heart disease by cholesterol levels at selected ages. , 2003, Archives of internal medicine.
[3] S. Grundy,et al. National Cholesterol Education Program Third Report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ) Final Report , 2022 .
[4] P. Poole‐Wilson,et al. Prevention of coronary heart disease in clinical practice , 1994 .
[5] W. Kannel,et al. The Framingham Offspring Study. Design and preliminary data. , 1975, Preventive medicine.
[6] G. Mancia,et al. Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. , 1998, Atherosclerosis.
[7] W. L. Beeson,et al. Effect of risk factor values on lifetime risk of and age at first coronary event. The Adventist Health Study. , 1995, American journal of epidemiology.
[8] R. D'Agostino,et al. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. , 2001, JAMA.
[9] Jeffrey J. Gaynor,et al. On the Use of Cause-Specific Failure and Conditional Failure Probabilities: Examples from Clinical Oncology Data , 1993 .
[10] D. Levy,et al. Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.
[11] R B D'Agostino,et al. Lifetime risk of dementia and Alzheimer's disease , 1997, Neurology.
[12] S. Cummings,et al. Lifetime risks of hip, Colles', or vertebral fracture and coronary heart disease among white postmenopausal women. , 1989, Archives of internal medicine.
[13] J. Mckenney,et al. National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2002 .
[14] Philip Greenland,et al. Prevention Conference V Beyond Secondary Prevention : Identifying the High-Risk Patient for Primary Prevention : Executive Summary , 2000 .
[15] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[16] W. Kannel,et al. AN APPROACH TO LONGITUDINAL STUDIES IN A COMMUNITY: THE FRAMINGHAM STUDY , 1963, Annals of the New York Academy of Sciences.
[17] V. Fuster,et al. Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. , 2000, Circulation.
[18] Sudha Seshadri,et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. , 2002, JAMA.
[19] R. D'Agostino,et al. Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: medical office assessment: Writing Group I. , 2000, Circulation.